Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

While ACE inhibitors and ARBs have been studied separately in African Americans, [5,6,7,8,9,10,11,12,13] comparative studies are scarce. Furthermore, it is not known whether these patients who do ...

ACE inhibitors are best known for treating high blood pressure. They work by targeting the hormone angiotensin II. Angiotensin-converting enzymes (ACE) inhibitors help blood vessels to relax and open.

Patients with sarcoidosis treated with ACE inhibitors had greater mortality risk than those treated with angiotensin receptor blockers.

In addition to their capacity to lower systemic blood pressure, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific ...

Other antihypertensive medications: These medications include high blood pressure medications like angiotensin converting enzyme (ACE) inhibitors. Combining these medications with ARBs could cause ...

This medication is an angiotensin-converting enzyme (ACE) inhibitor, prescribed for high blood pressure. This medication is an angiotensin-converting enzyme inhibitor (ACE inhibitor), prescribed ...

Routine use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is recommended in proteinuric nontransplant kidney disease patients, to reduce proteinuria and ...

Stating that angiotensin-II receptor blockers (ARBs) are an alternative treatment option for patients who do not tolerate ACE inhibitors falls short, as unlike ACE inhibitors, ARBs have not been ...

Patients with diabetes, kidney disease, and some types of heart disease also appear to get greater cardiovascular protection from ACE inhibitors and ARBs than from other blood pressure-lowering drugs.

Sacubitril/valsartan is more effective than angiotensin-converting enzyme (ACE) inhibitors in reducing hospitalization and mortality in HFrEF patients. Cost, side effects, and existing ACE ...

Angiotensin II receptor antagonists (A II) are another promising alternative therapy for patients who cannot use ACE inhibitors. Current clinical trials will help clarify the role of these drugs ...